Ken was Chief Financial Officer at Epic iO Technologies, and Co-Founder at Dimension Therapeutics. Ken Mills joined RegenxBio in 2024.
Ken Mills is currently
Create your alert
to follow the career of Ken Mills.
In 1997, Ken Mills completed a Bachelor of Science in Chemistry at Massachusetts Institute of Technology.
They have also studied at Massachusetts Institute of Technology :
Find more alumni from Massachusetts Institute of Technology
Do you need to know more about Ken Mills? More results.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.